Adimmune Corp (4142) — Cash Flow Reinvestment Rate
Adimmune Corp (4142) has a Cash Flow Reinvestment Rate of 0.09x as of December 2024, reinvesting NT$62.47 Million (capex NT$42.60 Million plus investments NT$19.87 Million) from operating cash flow of NT$658.32 Million. See Adimmune Corp free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Adimmune Corp Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Adimmune Corp across 6 annual periods. For the full cash flow conversion analysis, see Adimmune Corp cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Adimmune Corp (2007–2024)
Year-by-year capital reinvestment analysis for Adimmune Corp. See financial agility of Adimmune Corp to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.38x | NT$256.18 Million | NT$668.48 Million | NT$155.22 Million | ▲ +72.2% |
| 2020 | 0.22x | NT$516.76 Million | NT$2.32 Billion | NT$218.30 Million | ▼ -99.6% |
| 2017 | 61.73x | NT$424.37 Million | NT$6.87 Million | NT$11.35 Million | ▲ +4990.1% |
| 2010 | 1.21x | NT$626.30 Million | NT$516.39 Million | NT$626.30 Million | ▲ +3.5% |
| 2009 | 1.17x | NT$703.82 Million | NT$600.42 Million | NT$703.82 Million | ▼ -86.2% |
| 2007 | 8.50x | NT$265.77 Million | NT$31.26 Million | NT$265.77 Million | — |